SOURCES SOUGHT
65 -- Pulse Oximeter Sensors - Product Standardization
- Notice Date
- 4/8/2008
- Notice Type
- Sources Sought
- NAICS
- 423450
— Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- Contracting Office
- Bureau of Medicine and Surgery, NMC Portsmouth, 54 Lewis Minor St, Portsmouth, Virginia, 23708-2297
- ZIP Code
- 23708-2297
- Solicitation Number
- TMAR2-SS58
- Response Due
- 4/23/2008
- Point of Contact
- Lisa J Price,, Phone: 757-953-5737, Peggy K Klingensmith,, Phone: 757-953-7547
- E-Mail Address
-
lisa.price@med.navy.mil, peggy.klingensmith@med.navy.mil
- Description
- 65-Medical Supplies-Potential Sources Sought --------------- A. General Information NOTE: THIS ANNOUNCEMENT IS A COMPLETE REPLACEMENT FOR SOLICITATION NUMBER TMAR2-SS55. ALL INTERESTED VENDORS MUST SUBMIT FOR THE FIRST TIME OR RE-SUBMIT THEIR RESPONSES REFERENCING THE NEW SOLICITATION REFERENCE NUMBER ASSIGNED TO THIS ANNOUNCEMENT. The Tri-Service Mid-Atlantic Region, a military integrated delivery network, comprised of Army, Navy, Air Force, Marine Corps and Coast Guard medical commands and medical treatment facilities (MTFs) in the states of Virginia and North Carolina announces a Request for Regional Incentive Agreement Quotation (REFRIAQ) for the standardization of Pulse Oximeter Sensors, to include, but not limited to, sensors for the adult, pediatric, and neonatal patient population.. The major facilities in the area includes: 1st Medical Group, Langley AFB, VA; 43rd Medical Group, Pope AFB, NC; 4th Medical Group, Seymour Johnson AFB, NC; Womack Army Medical Center, FT Bragg, NC; McDonald Army Community Hospital, FT Eustis, VA; Kenner Army Health Clinic, FT Lee, VA; Naval Medical Center Portsmouth, Portsmouth, VA; Naval Hospital Camp Lejeune, Camp Lejeune, NC; Naval Hospital Cherry Point, Cherry Point MCAS, NC. The primary objective of this standardization initiative is to standardize the quality of care across this Region based on a best value determination that represents the clinically preferred product or source(s) at the best possible price. It is also intended that standardized products be obtained through the DoD Prime Vendor Program. This standardization action is part of the Medical/Surgical Prime Vendor program executed by the Defense Supply Center Philadelphia, Directorate of Medical Materiel. In order to participate, your company must have a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the Prime Vendor for the Mid-Atlantic Region (Owens & Minor). This is pursuant to the DAPA clause by which DAPA holders agree to the Standardization process and to allow Prime Vendors to distribute their items. This is a supplement to the Prime Vendor Program and it is not a contract. For additional information regarding DSCP’s Prime vendor program please access our web site at https://dmmonline.dscp.dla.mil The Mid-Atlantic Tri-Service Regional Business Office (TRBO) will provide anticipated volume (quantity) based on historical usage. The agreement will be for a base period of two (2) years (24 months) from date of award with three (3) 12-month option periods. Anticipated award date is July 2008. The evaluation will be based on clinical, technical, and pricing factors. The Technical/Company and Clinical/Performance evaluation factors, when combined, are considered significantly more important than cost or price. As the technical and clinical evaluation results become more equal, price will become more important. The selection will be determined utilizing best value/ trade-off criteria. The selection of a single vendor is anticipated. However, if no single vendor can meet the total requirement of the Region, the Government reserves the right to make two or more selections for RIAs. In this event, selection would be based on a combination of MTF preference and product availability. Point of Contact Robert Meinertzhagen, 757-953-2134, Bob.Meinertzhagen@med.navy.mil B.Products & Performance Required The Mid-Atlantic Region is seeking a complete product line of Pulse Oximeter Sensors, to include, but not limited to, sensors for the adult, pediatric, and neonatal patient population which includes at a minimum but is not limited to the high volume items indicated below. CDMIA SalesProduct Description $412,289.78Sensor Pulse Oximetry Disposable Adult/Neonatal Adhesive Strap 18in Cable f/Oxisensor II $112,923.92Sensor Pulse Oximetry Disposable Adult/Neonatal Adhesive Strap 18in Cable f/Oxisensor II $57,557.26Sensor Pulse Oximetry Disposable Infant Adhesive Strap 18in Cable f/Oxisensor II $22,932.17Sensor Pulse Oximetry Disposable Pediatric Adhesive Strap 18in Cable f/Oxisensor II $18,654.56Sensor Pulse Oximetry Disposable Adult Adhesive Strap 18in Cable f/Oxisensor II The approximate total annual purchase volume of all types of Pulse Oximeter Sensors is $650,593 for the Mid-Atlantic region and is based upon the historical usage of standardized Pulse Oximeter Sensors over a one year period. This is included as a reporting metric. The overall evaluation will be based upon clinical, technical and pricing factors. The final award recommendation will be determined by utilizing the best value and trade off criteria. At the request of the Mid-Atlantic Region Military Treatment Facilities, vendors will provide on-site support and in-servicing, educational resources and tools for clinical use of these products, conversion information, prime vendor order numbers, MSDS information, and itemization of the brands, types, and packaging information of the products offered by the vendor. C.Instructions to Vendors DAPA holders interested in participating in this standardization initiative, email your response to Bob.Meinertzhagen@med.navy.mil and provide: (1) Company name and address, (2) Point of contact information (Name and Phone Number, Fax Number, and E-mail address) (3) your company’s Distribution and Pricing Agreement (DAPA) number and (4) your companies responses to the questions under Technical/Company Criteria below. Your email will include your agreement to provide for your products necessary technical criteria, no charge samples for clinical evaluation, and submission of electronic best price offers that represent a discount from your companies base uncommitted DAPA pricing. All e-mail communication between vendors and the region will be digitally signed by the issuer. If required, any postal mailings should be sent to the following address: Robert Meinertzhagen Tri-Service Regional Business Office Financial Operations Department, Bldg. 250 Naval Medical Center Portsmouth 620 John Paul Jones Circle Portsmouth, VA 23708 Email responses must be received no later than 4:00 P.M. (EST) on the specified closing date/time of this Sources Sought FBO Notice. Failure to respond within this timeframe will result in your company being excluded from participation in this standardization effort. This process will include vendor requirements to provide electronic responses to technical criteria, no charge samples for clinical evaluation, and submission of electronic best price quotes. Due to the potential for email to become lost in transmission due to network security, etc., the vendor is strongly encouraged to confirm with the Region that its quote and literature actually arrived at the TRBO via email. We strongly recommend that each submitting vendor confirm receipt, allowing enough time for re-submission before the due date, if a problem should occur with the first transmission. Emails and correspondence may be sent to Bob.Meinertzhagen@med.navy.mil. D. Evaluation Criteria The Tri-Service Product Review Board (TPRB) is the governing board of the standardization process. This board includes clinicians and logisticians from all of the Military Treatment Facilities within the Mid-Atlantic Region. They are the decision makers for this initiative. Vendors will be required to provide responses to the technical/company criteria. The Region intends to evaluate price quotes and select a vendor or vendor(s), without discussions. Vendor quotes should contain the vendor's best product matches for the products or product lines requested in this announcement. Vendor quotes should contain the vendor's best responses to all technical and/or company questions listed in this announcement. Vendor quotes should contain the vendor's best tiered-pricing discounts off of the vendor's DAPA pricing (based on committed volume of 80% of the total requirements of the MTFs in the Region). Additionally, the Region reserves the right to conduct discussions and request revised quotes, if it is determined to be necessary. If a down-selection is made during the evaluation process, the Region may limit the number of quotes to the greatest number that will permit an efficient competition among vendors. 1.Vendors are required to provide responses to the technical/company criteria stated below. The responses will be reviewed under the purview of the Clinical Product Team (CPT) to determine the acceptability of each vendor. After review of the technical/company criteria, the Region will eliminate those vendors who fail to meet the criteria. The vendors who meet the following technical/company criteria will be qualified/invited to participate in the clinical/performance evaluation process via e-mail communication with each vendor. All communications of significant milestones, such as invitations to participate, notices of disqualification, etc. must be digitally signed. For those companies that meet the requirements above and the criteria below under Technical/Company Criteria, the CPT will request samples from the product group to be clinically evaluated at select Military Treatment Facilities (MTFs). Vendors are required to ship samples direct to the MTFs. Vendor samples must be received no later than 4:00 P.M., fourteen (14) calendar days after the request for samples is issued to the vendors. Vendors failing to comply by the deadline will be disqualified from further consideration in the standardization process. 1.To determine acceptability, a CPT comprised of medical professionals from the MTFs will evaluate the products based on the evaluation criteria below. It is intended that clinical evaluations shall be conducted in a non-clinical setting. However, the Government reserves the right to invoke evaluations in an inpatient setting. 2.The CPT will evaluate the products provided with the clinical/performance criteria identified in this announcement using a zero to seven rating scale. Zero is equal to not acceptable and seven is equal to highly acceptable. All criteria are weighted equally. The TPRB has set a 3.75 acceptability threshold for all products. Clinical/performance results lower than 3.75 will not be considered acceptable and will be disqualified from further consideration in the standardization process. 3.75 is a target acceptability threshold. The CPT will analyze this acceptability as being at or near 3.75 depending on the "break" in the average scores and how closely scores are clustered near the 3.75. Below this threshold, products will be unacceptable clinically and not eligible for consideration for standardization and will not be considered further 3.After the clinical/performance evaluations are completed and analyzed, all vendors in the clinical evaluation group who met the 3.75 threshold will be asked to submit their best pricing offer representing a discount from their DAPA pricing based on a minimum committed volume of 80% of the total requirements for MTFs in the Mid-Atlantic Region. Vendors that fail to offer pricing that is discounted from their DAPA pricing will be eliminated from further consideration. Vendor Product and Price Proposals will be in the Excel template provided by the government. The vendors will provide their completed Excel template by email to Bob.Meinertzhagen@med.navy.mil. Pricing responses must be received by 4:00 P.M. fourteen (14) calendar days from the date the request is initiated by the TRBO. Failure to respond within this timeframe will result in your company being excluded from further participation/consideration. Technical/Company Criteria: The CPT will review the following technical criteria responses from each vendor and determine acceptability. Acceptability for the purpose of evaluation of the technical criteria means the responses to all questions in this section demonstrate that: (1) the vendor offering the quote is a distributor or manufacturer of a complete line of the subject medical/surgical consumables; (2) based on the vendor’s responses, the evaluators have reasonable confidence that the product line or products and/or services offered meet the medical standards of care of the community in which such products and/or services are applicable; (3) the vendor has a DAPA for the product line, products and/or services; (4) the vendor has a commercial agreement covering the product line, products and/or services with Owens and Minor, the Prime Vendor for the region ; (5) the vendor intends to offer discounts off DAPA for all products included in this standardization initiative (vendors that fail to offer a discount from DAPA will be disqualified); and (6) the vendor’s information provided is factually correct. Any misrepresentation of information will disqualify the vendor from further consideration. Vendors must provide a response to each criteria listed below: 1. Vendors are required to provide a full line of a full line of Pulse Oximeter Sensors for adult, pediatric, and neonate patient populations. The ability for the vendor to provide these items is considered critical and failure to do so will result in the vendor not being included in this standardization effort. 2. Vendor’s Pulse Oximeter Sensors must be available through the regional Prime Vendor, Owens & Minor. Companies that do not have a distribution contract/agreement with the Prime Vendor will be eliminated from further consideration. 3. Vendors are required to provide their DAPA Number. Vendors that fail to have a DAPA will be disqualified from further consideration. 4. Vendors must offer discounts from the DAPA pricing for all products included in this standardization initiative. Vendors that fail to offer a discount from DAPA will be disqualified. Where lower FSS prices are available, DAPA holders are required by previous agreement to provide the FSS price as their DAPA price. Therefore, FSS prices do not represent discounts off the DAPA. 5. Vendors must identify if products are latex free/safe and labeled appropriately 6. Vendors are required to provide the brands their company manufactures and/or distributes. 7. Vendors are required to provide a list of styles and sizes for the products their company offers. 8. Vendors must provide the following information for each Pulse Oximeter Sensor product line their company offers: a.Describe/discuss the materials from which the sensor is manufactured and associated durability. b.Describe/discuss the compatibility with other manufacturers monitors (oximetry and physiologic). c.Describe/discuss the availability of single use and reusable sensors and the capability of the sensors to be recycled and/or reprocessed. d.Describe/discuss the availability/capability of sensors for use when a finger sensor is not appropriate. e.Describe/discuss the ability of the sensors to function accurately through motion, during low perfusion states, and under extremes of pressure and temperature. f.Describe/discuss the sensitivity of the sensors as concerns weak or extraneous signals and the length of time for signal transmission to the monitor. g.Describe/discuss the accuracy of the oxygen saturation measurement within the range of 70 – 99%. h.Describe/discuss the capability of the sensor to travel with the patient and the capability to be utilized with a handheld, continuous and multiparameter monitor. i.Describe/discuss the availability of sterile packaging for the sensors. j.Describe/discuss the ability to identify/determine product number, size, and lot number from the packaging. 9. Describe/discuss the testing, and standards, your company uses to determine the quality of your products. 10. Describe/discuss the types of educational tools or materials available for this product line. 11. Describe/discuss your company’s customer service policy and program. 12. Vendors must indicate that they agree to provide sample products to the designated Medical Treatment Facilities by 4:00 PM EST within 14 calendar days of the government’s request and that all samples will be at no charge or liability to the government. 12. Vendors must indicate that, upon request, they can provide electronic and hard copy proposed pricing and competitive product cross reference in electronic Microsoft Excel format within 14 days of request by the government. 13. Vendors must provide any history of backorders and/or recalls for this product group. If any, please provide: Dates and duration Cause Resolution Vendors should provide a context to include any mitigating factors for any situations identified, and any relief of resolution which may have been provided since there will be no further opportunity to explain these scenarios and their effects subsequent to the FBO Announcement. 14. Vendors will describe, as applicable, any features that their products have that would be considered new technology and any product advancements that are anticipated. Clinical/Performance Criteria: 1. Compatibility of sensor with monitoring equipment utilized in your facility 2. The sensor maintains necessary skin-to-sensor contact upon multiple patient repositioning 3. Ease of sensor removal/re-positioning while maintaining patient skin integrity 4. Maintenance of signal during motion 5. Adequacy/security of cable-to-equipment connection 6. Adequacy/security of sensor-to-cable connection
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=6814cb5c0678fda1d2cfb99d08dc6b3a&tab=core&_cview=1)
- Place of Performance
- Address: Naval Medical Center, 620 John Paul Jones Circle, Portsmouth, Virginia, 23708, United States
- Zip Code: 23708
- Zip Code: 23708
- Record
- SN01549482-W 20080410/080408222221-6814cb5c0678fda1d2cfb99d08dc6b3a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |